Search results
Results from the WOW.Com Content Network
BofA Securities has upgraded Inspire Medical Systems, Inc. (NYSE:INSP) and says the company now falls in the profitable growth category. Inspire Medical is expected to give its 2025 revenue ...
MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended September 30, 2024.
MINNEAPOLIS, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London ...
Inspire (INSP) delivered earnings and revenue surprises of 21.79% and 6.95%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of ...
Also in 2019, Inspire collaborated with Isabelle Boutron, a professor of epidemiology at the Paris Descartes University and head of the INSERM- METHODS team within the Centre of Research in Epidemiology and Statistics (CRESS), on BioMed Central," a study about "spin" in healthcare news. [15] In April 2018, an Inspire data scientist was an ...
Inspire Medical Systems, Inc. Health Care Health Care Equipment Golden Valley, Minnesota: view: 0001609550 INVA: Innoviva, Inc. Health Care Pharmaceuticals
In 2009, he was the recipient of the Massachusetts Society for Medical Research Award. He was listed in Forbes - The Midas 100 of Top Tech Investors for 2011, [ 4 ] the 2013 Top 10 Life Sciences Investors, [ 5 ] and again to the Midas 100 list in 2014. [ 6 ]